Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells
Summary. Background: Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder associated with the activity of BCR-ABL fusion oncogene. Tyrosine kinase inhibitors are the current treatment of CML, but secondary mutations finally contribute to therapy resistance and blast crisis of...
Saved in:
| Date: | 2018 |
|---|---|
| Main Authors: | Shvachko, L.P., Zavelevich, M.P., Gluzman, D.F., Kravchuk, I.V., Telegeev, G.D. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2018
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
-
Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E
by: Shvachko, L.P., et al.
Published: (2023) -
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
by: Antonenko, S.V., et al.
Published: (2023) -
Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
by: Perekhrestenko, T., et al.
Published: (2023) -
Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
by: Ivanivska, T.S., et al.
Published: (2023) -
Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79,524 patients from Latvia
by: Gavars, D., et al.
Published: (2023)